Your activity: 61 p.v.
< Back
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Available FDA-approved medications for the prevention of osteoporosis in postmenopausal women*

Available FDA-approved medications for the prevention of osteoporosis in postmenopausal women*
Drug class Medication Dose
Estrogens Many Variable
Bisphosphonates Alendronate 35 mg/week or 5 mg/day
Risedronate 35 mg/week, 5 mg/day, or 150 mg/month
Ibandronate 150 mg/month
Zoledronic acid 5 mg IV once every two years
Selective estrogen receptor modulators (SERMs) Raloxifene 60 mg/day
Bazedoxifene - conjugated equine estrogen 20 mg/0.45 mg daily
FDA: US Food and Drug Administration; IV: intravenous.
* There are no FDA-approved medications for prevention of osteoporosis in men.
Graphic 64685 Version 8.0